Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Exenatide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    CLINICAL TRIALS

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amneal Resubmits DHE Autoinjector NDA; FDA Approves Exenatide
    Amneal Resubmits DHE Autoinjector NDA; FDA Approves Exenatide

    22 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241121053036/en

    BUSINESSWIRE
    22 Nov 2024
    Share Share
    Vivani Medical Announces Positive Preclinical Liver Fat Results GLP-1 Implant
    Vivani Medical Announces Positive Preclinical Liver Fat Results GLP-1 Implant

    04 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240904740218/en

    BUSINESSWIRE
    04 Sep 2024
    Share Share
    Vivani Medical Reports Q2 2024 Results And Business Update
    Vivani Medical Reports Q2 2024 Results And Business Update

    13 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240813624656/en

    BUSINESSWIRE
    13 Aug 2024
    Share Share
    Vivani Medical Updates On Long-Term GLP-1 Obesity Implant Program
    Vivani Medical Updates On Long-Term GLP-1 Obesity Implant Program

    11 Jul 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240711383258/en

    BUSINESSWIRE
    11 Jul 2024
    Share Share
    Vivani Gets FDA IND Clearance, Clinical Hold Lifted For GLP-1 Implant NPM-119
    Vivani Gets FDA IND Clearance, Clinical Hold Lifted For GLP-1 Implant NPM-119

    13 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240613953589/en

    BUSINESSWIRE
    13 Jun 2024
    Share Share
    UK probes GLP-1 drugs' potential suicide risks
    UK probes GLP-1 drugs' potential suicide risks

    27 Jul 2023

    // Angus Liu FIERCE PHARMA

    https://www.fiercepharma.com/pharma/glp-1-drugs-novo-az-lilly-and-sanofi-under-uk-probe-over-their-suicide-risks-reuters

    Angus Liu FIERCE PHARMA
    27 Jul 2023
    Share Share